The Supreme Court of the United States will examine a sensitive issue this Tuesday, March 26, the abortion pill. The decision could have serious consequences, and not only on abortion, but for the entire pharmaceutical industry, many experts believe.
This pill, authorized since 2000 by the FDA (Food and Drug Administration), the American drug agency, has benefited from extended access since 2016. If by chance the Supreme Court aligns with this judgment, it would be an unprecedented decision, experts believe, with serious consequences for the pharmaceutical industry.